Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$112.16 - $174.14 $11,216 - $17,414
-100 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$58.05 - $111.31 $696 - $1,335
-12 Reduced 10.71%
100 $11,000
Q2 2020

Aug 14, 2020

SELL
$57.2 - $74.41 $163,420 - $212,589
-2,857 Reduced 96.23%
112 $6,000
Q4 2019

Feb 12, 2020

BUY
$68.3 - $93.8 $7,308 - $10,036
107 Added 3.74%
2,969 $249,000
Q3 2019

Nov 14, 2019

BUY
$61.86 - $97.8 $102,811 - $162,543
1,662 Added 138.5%
2,862 $213,000
Q2 2019

Aug 13, 2019

BUY
$42.22 - $63.23 $50,664 - $75,876
1,200 New
1,200 $75,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.69B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.